This statistic shows the flow of payments for a hypothetical insulin that costs 400 U.S. dollars while the patient has health coverage with a high deductible from the employer , as of 2017 . According to the source , in such a case , the manufacturer retains 88 U.S. dollars while the health insurance plan/plan sponsor retains 239 dollars .
